Detalles de la búsqueda
1.
Durable response of lung carcinoma patients to EGFR tyrosine kinase inhibitors is determined by germline polymorphisms in some immune-related genes.
Mol Cancer
; 22(1): 120, 2023 07 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37516818
2.
Exome-Based Genomic Markers Could Improve Prediction of Checkpoint Inhibitor Efficacy Independently of Tumor Type.
Int J Mol Sci
; 24(8)2023 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37108755
3.
Molecular intrinsic subtypes, genomic, and immune landscapes of BRCA-proficient but HRD-high ER-positive/HER2-negative early breast cancers.
Breast Cancer Res
; 24(1): 80, 2022 11 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36401316
4.
Smartphone-based application and nurses' interventions for symptoms monitoring in patients treated with oral anticancer agents: A 1-year follow-up in a tertiary cancer center.
J Oncol Pharm Pract
; : 10781552221117731, 2022 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35938191
5.
Carboplatin and Etoposide for the Treatment of Metastatic Prostate Cancer with or without Neuroendocrine Features: A French Single-Center Experience.
Cancers (Basel)
; 16(2)2024 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38254771
6.
Prognostic stratification ability of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy.
Eur J Cancer
; 202: 114037, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38554542
7.
Pharmacokinetics and Pharmacodynamic of Alpelisib.
Clin Pharmacokinet
; 62(1): 45-53, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36633813
8.
Taxane rechallenge during metastatic disease in HER-2 negative breast cancer patients: Clinical activity, tolerance and survival results.
Breast
; 68: 149-156, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36773403
9.
Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer.
Cancers (Basel)
; 15(4)2023 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36831640
10.
Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy.
Breast Cancer
; 30(6): 997-1007, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37561255
11.
Is There a Role for Large Exome Sequencing in the Management of Metastatic Non-Small Cell Lung Cancer: A Brief Report of Real Life.
Front Oncol
; 12: 863057, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35330711
12.
Small Cell Neuroendocrine Carcinoma of the Paranasal Sinuses with Unexpected Location and Clinical Presentation and Occupational Exposure: A Case Report.
Am J Case Rep
; 23: e934980, 2022 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35232952
13.
MER4 endogenous retrovirus correlated with better efficacy of anti-PD1/PD-L1 therapy in non-small cell lung cancer.
J Immunother Cancer
; 10(3)2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35277462
14.
Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencing.
NPJ Breast Cancer
; 8(1): 28, 2022 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35246547
15.
Uncommon EGFR mutations in lung carcinoma: features and treatment outcomes in a retrospective French cohort.
J Thorac Dis
; 14(6): 2034-2044, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35813741
16.
MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells.
Cancer Cell
; 40(2): 136-152.e12, 2022 02 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35051357
17.
Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.
Eur J Cancer
; 165: 13-24, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35189537
18.
Splenic Volume as a Surrogate Marker of Immune Checkpoint Inhibitor Efficacy in Metastatic Non Small Cell Lung Cancer.
Cancers (Basel)
; 13(12)2021 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34208673
19.
Population Pharmacokinetics of Palbociclib in aReal-World Situation.
Pharmaceuticals (Basel)
; 14(3)2021 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33668400
20.
Pharmacokinetic/Pharmacodynamic Model of Neutropenia in Real-Life Palbociclib-Treated Patients.
Pharmaceutics
; 13(10)2021 Oct 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34684001